A few cases of alcohol-like chronic liver disease have recently been described in patients on
high daily doses of amiodarone (400–600 mg) for 5–24 months. We report here 3 cases in …

Hepatic dysfunction, most commonly an elevation of aminotransferases, develops in 15% to
40% of patients receiving amiodarone (1). However, acute hepatitis induced by parenteral …

A patient with acute changes suggesting acute hepatitis after parenteral amiodarone
administration is described. A 77‐year‐old man with previous myocardial infarction was …

Amiodarone remains the agent of choice for the 80 mmHg and clinical and radiological
evidence of management of atrial fibrillation in unstable patients fluid overload. He was …

Two fatal cases of amiodarone-induced acute, confluent, necrotic hepatitis are described.
The patients, aged 28 and 60, had received a high loading dose of amiodarone. After the …

Abstract Amiodarone [2-butyl-3-(3′, 5′-diiodo-4'α-diethylaminoethoxybenzoyl)-
benzofuran](AMD), a class III antiarrhythmic drug, is known to cause idiosyncratic …

A60-year-old man with medical history of atrial fibrillation on amiodarone 400 mg/d for 8
years was admitted for increased shortness of breath. On his general physical examination …

Objectives Amiodarone is widely used to treat arrhythmia. However, amiodarone is known
for its severe toxicity to the liver, lungs, and thyroid. Amiodarone causes liver damage …

Drug‐induced liver injury (DILI) is the most frequent cause of post‐marketing warnings and
withdrawals. Amiodarone (AMD), an antiarrhythmic, presents a risk of liver injury in humans …

Acute burn and trauma patients have a higher frequency of cardiac arrhythmias than would
be expected for noncardiac-hospitalized patients. Amiodarone is an effective, commonly …